Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Clinical trial NCT02366819 · SUSPENDED

Trial details

NCT number: NCT02366819
Sponsor: University of Chicago
Status: SUSPENDED
Phase: Phase 4
Study type: INTERVENTIONAL

Esophageal Adenocarcinoma Gastric Adenocarcinoma Stage IIB Gastric Cancer Stage IIIA Esophageal Adenocarcinoma Stage IIIA Gastric Cancer Stage IIIB Esophageal Adenocarcinoma Stage IIIB Gastric Cancer Stage IIIC Esophageal Adenocarcinoma Stage IIIC Gastric Cancer

Start date: 2014-12-11
Primary completion: 2026-06-08
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.